Disease severity evaluation among dermatological out-patients: A comparison between the assessments of patients and physicians

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 2, 2012, Pages 213-218

  Tabolli, S ^a   Sampogna, F ^a   Pagliarello, C ^a   Paradisi, A ^a   Spagnoli, A ^a   Abeni, D ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERSONAL EXPERIENCE; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SEX DIFFERENCE; SKIN DISEASE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; MALE; OUTPATIENTS; PATIENTS; PHYSICIANS; QUESTIONNAIRES; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SKIN DISEASES;

EID: 84856317229     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04038.x     Document Type: Article

References (25)

1. Feldman SR, Fleischer AB, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-186. (Pubitemid 26052065)
2. Hayashi N, Akamatsu H, Kawashima M, Acne Study Group. Establishment of grading criteria for acne severity. J Dermatol 2008; 35: 255-260. (Pubitemid 351678090)
3. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-447.
4. Ludwig E,. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-257.
5. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001; 10: 11-18. (Pubitemid 32098039)
6. Grekin SJ, Charles E,. Evaluating the severity of dermatologic disorders. Dermatol Ther 2009; 22: 191-198.
7. Tabolli S, Sampogna F, Di Pietro C, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol 2009; 161: 869-877.
8. Rohekar G, Pope J,. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Reumathol 2009; 36: 2178-2182.
9. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermat 1996; 107: 707-713. (Pubitemid 26371086)
10. Sampogna F, Sera F, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602-607. (Pubitemid 38471324)
11. Sampogna F, Picardi A, Melchi CF, et al. The impact of skin diseases on patients: comparing dermatologists' opinions with research data collected on their patients. Br J Dermatol 2003; 14: 989-995. (Pubitemid 36750793)
12. Sampogna F, Soderfeldt B, Axtelius B, et al. Comparison of patients' and provider' severity evaluation of oral mucosal conditions. J Am Acad Dermatol; doi: (in press).
13. European Medicine Agency. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products EMEA/CHMP/EWP13939/2004 London, 2004. Available at:.
14. Szende A, Leidy NK, Revicki D,. Health-related quality of life and other patient-reported outcomes in the european centralized drug regulatory process: a review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value Health 2005; 8: 534-548. (Pubitemid 41727305)
15. Nijsten T, Sampogna F, Abeni D,. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009; 218: 151-154.
16. Rosso S, Miñarro R, Schraubc S, Tuminod R, Franceschie S, Zanetti R,. Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol 2002; 31: 439-446. (Pubitemid 34537809)
17. StataCorp. Stata Statistical Software: Release 9. StataCorp LP, College Station, TX, 2005.
18. Fleiss JL,. Statistical Methods for Rates and Proportions, 2nd edn. John Wiley, New York, 1981
19. Renzi C, Abeni D, Picardi A, et al. Factor associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001; 145: 617-623.
20. Paradisi A, Sampogna F, Di Pietro C, et al. Quality of life assessment in patients with pemphigus using a minimum set of evaluation tools. J Am Acad Dermatol 2009; 60: 261-269.
21. Chren MM, Lasek RJ, Flocke SA, Zyzonski SJ,. Improve discriminative and evaluative capability of a refined version of Skindex, a quality of life instrument for patient with skin disease. Arch Dermatol 1997; 133: 1433-1440. (Pubitemid 27490569)
22. Feldman SR, Krueger GC,. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005; 64 (Suppl. 2): ii65-Ii68. (Pubitemid 40288526)
23. Hays RD, Vickrey BG, Hermann BP, et al. Agreement between self report and proxy reports of quality of life in epilepsy patients. Qual Life Res 1995; 4: 159-168.
24. Novella JL, Jochum C, Jolly D, et al. Agreement between patient' and proxies' reports of quality of life in Alzheimer's diseases. Qual Life Res 2001; 10: 443-452. (Pubitemid 33081999)
25. Sampogna F, Tabolli S, Söderfeldt B, et al. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006; 154: 844-849.